Results 181 to 190 of about 28,511,988 (353)

Data Science at the Singularity

open access: yesHarvard Data Science Review
A purported `AI Singularity' has been in the public eye recently. Mass media and US national political attention focused on `AI Doom' narratives hawked by social media influencers. The European Commission is announcing initiatives to forestall `AI Extinction'.
openaire   +3 more sources

Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab

open access: yesMolecular Oncology, EarlyView.
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton   +17 more
wiley   +1 more source

Dose‐dependent induction of epithelial‐mesenchymal transition in 3D melanoma models by non‐thermal plasma treatment

open access: yesMolecular Oncology, EarlyView.
Non‐thermal plasma treatment of melanoma cells induced epithelial‐mesenchymal transition (EMT) in a dose‐dependent fashion. This report highlights the critical need to further investigate potential adverse effects of non‐thermal plasma for cancer therapy and to optimize treatment parameters for clinical translation. Despite the promising results of non‐
Eline Biscop   +10 more
wiley   +1 more source

Revisiting community engagement methods in the context of data science research and big data use in South Africa

open access: yesSouth African Journal of Science, 2023
Gonasagrie Nair   +4 more
doaj   +1 more source

Partial differential equations in data science. [PDF]

open access: yesPhilos Trans A Math Phys Eng Sci
Bertozzi AL   +3 more
europepmc   +1 more source

Report of the Committee on Sensory Data to the Journal Management Committee of the American Dairy Science Association

open access: bronze, 1986
Earl G. Hammond   +4 more
openalex   +1 more source

Molecular imaging predicts trastuzumab‐deruxtecan (T‐DXd) response in head and neck cancer xenograft models

open access: yesMolecular Oncology, EarlyView.
Trastuzumab‐deruxtecan, a HER2‐targeting antibody‐drug conjugate, shows promising antitumor activity in head and neck squamous cell carcinoma with low HER2 expression. In vitro and in vivo studies demonstrated dose‐dependent cell death and tumor growth reduction in low HER2‐expressing cell lines, which correlated with drug accumulation measured using a
Abdullah Bin Naveed   +8 more
wiley   +1 more source

Big Research Data and Data Science

open access: yesData Science Journal, 2015
Jianhui Li
doaj   +1 more source

Home - About - Disclaimer - Privacy